ALBANY, N.Y. - The Partnership to Advance Clinical electronic Research (PACeR), a broad-based health care collaborative, aims to make clinical trials faster and less expensive by identifying potential candidates more efficiently and enhancing protocol modeling and data collection. To achieve this, PACeR is working to create an electronic clinical data process for evidence-based research in New York State.
Most importantly, by testing and making needed therapies available to patients faster, PACeR will help improve the quality of life for patients.
A Strong Model with Benefits for All Stakeholders
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Launched in 2010, PACeR's first phase of work confirmed the feasibility of developing a sophisticated, statewide clinical data process for evidence-based research and offered a plan to address the challenges and improvement opportunities associated with the design of existing electronic medical records (EMRs) and patient health data confidentiality.
Fewer protocol amendments and more rapid patient recruitment and enrollment can result in earlier, less expensive product launches, and significant benefits to patients from earlier access to innovative therapies. PACeR's revenue potential for clinical study protocol modeling alone is substantial: more than $50 million annually. PACeR Phase 1 estimates show that for an average protocol, modeling, and amendments savings will range from $100,000 to $200,000 per protocol, and cost reductions associated with trial conduct will range from $400,000 to $500,000.
PACeR's Phase 1 results also point to significant benefits for major health care stakeholders, including patients, academic medical centers, the research community, health information technology companies (HIT), regulators, public and private initiatives, and the State of New York.
A white paper describing PACeR's Phase I results and Phase 2 plans is available online at www.pacerhealth.org.
Who Is PACeR?
PACeR is a collaborative of leading medical research centers, pharmaceutical companies, and HIT organizations. Participants include:
* Sponsor: Healthcare Association of New York State (HANYS)
* Patient Advocacy Groups: The Hastings Center and Legal Action Center
* Academic Medical Centers: Albany Medical Center, Bassett Medical Center, Continuum Health Partners (St. Luke's-Roosevelt Hospital and Beth Israel Medical Center), New York Hospital Queens, North Shore-Long Island Jewish Health System, NYU Langone Medical Center, Roswell Park Cancer Institute Corporation, Stony Brook University Medical Center, SUNY Downstate Medical Center, SUNY Upstate University Hospital, University of Rochester Medical Center, Weill Cornell Medical College, and Westchester Medical Center